InvestorsHub Logo
Followers 4
Posts 316
Boards Moderated 0
Alias Born 06/29/2021

Re: None

Tuesday, 08/01/2023 7:19:52 PM

Tuesday, August 01, 2023 7:19:52 PM

Post# of 462330
Q3

In the hands of the FDA
Anavex will likely present and publish in a peer-reviewed journal the Phase 2b/3 data in Q1 2023. Emergency approval by the FDA could come in Q2 2023.
Jan 30, 2023

Slow Poke TGD
Nothing happened
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News